FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

COR

CencoraNYSE · Health Care Distributors · Health Care
Previous close
318.50
Change
−4.79 / −1.48%
FinDog View
Neutral
52-Week Range
244.82 – 377.54
P/E (TTM)
23.5
Forward P/E
16.0
Based on consensus earnings for the next 12 months
Market Cap
$60.8B
1M
+1.91%
S&P 500 −2.41% over same period
Volume / Avg Volume
931K / 1.2M
0.77× average

Price History

Closing price · USD1M6M1Y5Y
100200300400FY26 Q3 EarningsFY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 EarningsFY25 Q2 Earnings2021-092022-122024-032025-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 23.91M6M1Y5Y
10203040502026-032026-052026-062026-082026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q3
Quarter ended 2026-06
2026-08-05$84.8B4.48 / 4.39+2.46%Read analysis →
FY2026 Q2
Quarter ended 2026-03
2026-05-06$78.4B4.75 / 4.86+1.16%Pending
FY2026 Q1
Quarter ended 2025-12
2026-02-04—— / —+6.72%Pending
FY2025 Q4
Quarter ended 2025-09
2025-11-05—— / —+1.76%Pending
FY2025 Q3
Quarter ended 2025-06
2025-08-06—— / —−1.90%Pending
FY2025 Q2
Quarter ended 2025-03
2025-05-07—— / —−6.83%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 15 of its 5-year rangeCheap
5-year range 21.7 – 44.0 · Median 27.0
Last 4 quarters: $71,000 in buybacks + $468M in dividends, 0.77% of market cap combined
P/E (TTM)
23.5
P/B
20.2
P/S
0.2
Dividend Yield
1.01%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.5% on average on the first trading day after, rising 4 times
Most recent +2.46%
Volatility & Correlation
1-year beta -0.17 · Correlation with S&P 500 -0.07Low beta
Annualized volatility 31% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 2 · $1.2MSell 2 · $4.0MNet selling $2.7M
  • 09-01Krikorian LazarusSVP & Chief Accounting OfficerSell$0.32M985 shares · Avg price 325.97
  • 08-24Campbell Elizabeth SExecutive Vice PresidentSell$3.7M11,300.471 shares · Avg price 324.12
  • 06-22Tyler Lauren MDirectorBuy$0.15M550 shares · Avg price 270.23
  • 06-18DURCAN DERMOT MARKDirectorBuy$1.1M4,000 shares · Avg price 274.19
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q384.75+5.1%4.3%1.120.762.433.94
FY2026 Q278.36+3.8%4.6%1.141.641.178.40
FY2026 Q185.93+5.5%3.6%0.760.56-2.422.87
FY2025 Q483.73+5.9%3.5%0.02-0.342.88-1.74
FY2025 Q380.66+8.7%3.6%0.870.69-0.073.52
FY2025 Q275.45+10.3%4.1%1.040.723.223.68
FY2025 Q181.49+12.8%3.1%0.710.49-2.822.50
FY2024 Q479.05+14.7%3.2%0.130.000.820.04
FY2024 Q374.24+10.9%3.2%0.670.482.362.42
FY2024 Q268.41+7.8%3.7%0.550.42-0.992.09
FY2024 Q172.25+15.0%3.4%0.820.600.812.98
FY2023 Q468.92+12.7%3.3%0.480.351.651.72

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
CORCencora$60.8B23.5+5.1%4.3%+1.91%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare